BGM
NASD BGM Group Ltd. Class A$9.34 ↑ +0.00 (+0.00%) Trading Up from the previous close of $9.34, $0.57 below the day’s high of $9.91
- YTD change
- -91.56%
- vs 20-day SMA
- +19.68%
- vs 200-day SMA
- -70.17%
Price ranges
Price & Performance
+9.01 (+2703.12%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 98.2% away from all-time highs of $515.10
- BGM is down 92% since the beginning of the year
- BGM is down 97% over the past 12 months
- BGM is up 11% over the past 1 month
- 3% of all BGM investors are betting against BGM
BGM reads neutral: price sits above one of the two key moving averages, the 12-month move is -2.4%.
- Previous minute
- +$0.11
- Last hour
- +$0.00
- Last 5 days
- +25.18%
- vs 8-day SMA
- +24.09%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
BGM Group Ltd. is a holding company, which engages in the technology fields of AI application, intelligent robots, algorithmic computing power, cloud computing, and biopharmaceuticals. It operates through the following segments: Oxytetracycline and Licorice Products, and Traditional Chinese Medicine Derivatives (TCMD); Heparin Products and Sausage Casing; and Fertilizer. The Oxytetracycline and Licorice Products, and TCMD segment focuses on the development, manufacture, marketing, and sale of oxytetracycline products, licorice products, and TCMD. The Heparin Products and Sausage Casing segment treats cardiovascular diseases, cerebrovascular diseases, and hemodialysis. The Fertilizer segment includes Xiongguan, Organic Fertilizer and Xiongguan, and Organic-Inorganic Compound Fertilizer. The company was founded on February 7, 2019 and is headquartered in Chengdu, China.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.